FDA Investigator Raquel Gonzalez Rivera

Raquel Gonzalez Rivera has conducted inspections on 35 sites in 8 countries as of 13 Jul 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
35
Last Inspection Date:
13 Jul 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Germany, Hungary, Puerto Rico, Ireland, India, Mexico, Austria, China
FDA Investigators that have inspected at least one site in common with Raquel Gonzalez Rivera:
Adalberto Cajigas, Adaliz Santaliz Cruz, Agnes M Santori, Alan A Rivera, Alan P Kurtzberg, Alicia M Mozzachio, Ana M Rivera, Anastasia G Lolas, Angelica M Hernandez, Anissa M Vargas, Ann L Demarco, Anna Lazar, Annette Melendez, Anthony A Charity, Ariel Cruz Figueroa, Arlene M Badillo, Arwa S El Hagrasy, Azza Talaat, Binh T Nguyen, Bo Chi, PhD, Brenda Rivera, Burnell M Henry, Carlos A Medina, Carolyn A Renshaw, Cassandra L Abellard, CDR Ileana Barreto Pettit, Charisse K Green, Christina Capacci Daniel, PhD, Christopher T Middendorf, Colleen Thomas, PhD, Concepcion Cruz, Jr, Cynthia Jim, CSO, Daniel L Obrzut, Dayna I Martinez, Dennis Cantellops Paite, Deyaa Shaheen, Diane L Raccasi, Doan T Nguyen, PharmD, Donna Christner, Douglas C Kovacs, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Zhihao Qiu (Peter), PhD, Edwin Martinez, Edwin Melendez, Edwin Ortega, Erika V Butler, Felix Maldonado, Francis A Guidry, German Rivera, Guo Q Shen, Gwyn G Dickinson, Helen B Ricalde, Helen Verdel, Heriberto Negron Rivera, Holly Brevig, Iraida Ortiz, Ivis L Negron, Jacqueline Mdiaz Albertini, Javier O Vega, Jessica L Pressley, Joan M Cantellops Figueroa, Joel D Hustedt, Jonah S Ufferfilge, Jonathan G Matrisciano, Jorge E Martinez, Jorge L Gonzalez, Jorge L Guadalupe, Jorge L Lajara, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, José E Meléndez, Jose F Pedro, Jose M Cayuela, Jose R Lopez, Jose Rflores Veguilla, Jose Velez, Joseph A Piechocki, Juan Rjimenez Garcia, June P Page, Junho Pak, Justin A Boyd, Karen E D'orazio, Karl D Hezel, Kent C Faul, Kevin A Gonzalez, Kham Phommachanh, Krishna Ghosh, PhD, Laiza V Garcia, Lareese K Thomas, Laura E Garcia, Laurimer Kuilan Torres, Libia M Lugo, Linda Thai, Lisa M Lopez, Lisa Shin, Lloyd D Payne, Lourdes Andujar, Lourdes Valentin Aponte, Lucas B Leake, Luis A Carrion, Luis Soto Lopez, Marcellinus D Dordunoo, Maria Cecilia Tami, PhD, Maria Joselopez Barragan, PhD, Marian E Ramirez, Marianela Aponte Cruz, Mary E Farbman, PhD, Matthew B Casale, Michael A Charles, Michael A Taylor, Michael R Goga, Michele L Obert, Michelle Yclark Stuart, Miguel A Martinez Perez, Miguel Hernandez Sanchez, Milva E Melendez Perales, Min Tang, Moraima Jramos Valle, Mra Davism, Mra Mcculloughj, Muralidhara B Gavini, PhD, Myriam M Sosa, Nancy Rosado, Noreen Muñiz, Omotunde O Osunsanmi, Pablo Feliciano, Pankaj H Amin, Patrick C Klotzbuecher, Patrick L Wisor, Patsy J Domingo, Peter E Baker, Prabhu P Raju, Prajakta A Varadkar, Pratik S Upadhyay, DDC, Rafael Nevarez Nieves, Ram Sihag, PhD, Ramesh Potla, PhD, Ramon A Hernandez, Rapti D Madurawe, Rebeca M Melendez, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Richard Ledwidge (nmi), PhD, Rita K Kabaso, Robert M Barbosa, Rochelle L Cross, Rose Ashley, Rumany C Penn, PharmD, S Lori Brown, PhD MPH, Samina S Khan, Sang Bong Lee, Santos E Camara, Saundrea A Munroe, Sharmista Chatterjee, Sharon K Thoma, PharmD, Shirley J Berryman, Simone E Pitts, Sixto M Mercado Rios, Sonia M Monges, Sonia R Peterson, Sony Mathews, Stephanie A Slater, MS, Stephen J Koniers, Steven B Barber, Steven E Bowen, PhD, Steven Fong, MS, PhD, Tamil Arasu, PhD, Terri L Dodds, Thomas J Arista, Thuy T Nguyen, LCDR, Tiffani D Wilson, Unnee Ranjan, Veronica Fuentes, MS, Vilmary Negron Rodriguez, Vincent Thomas, Viviana Matta, Vlada Matusovsky, Wanda J Torres, Wayne E Seifert, Xiaokuang Lai, PhD, Yasamin Ameri, Yifan Wang, Ying Zhang, Yumi J Hiramine, Yvesna C Blaise, Zachary L Stamm

Raquel Gonzalez Rivera's Documents

Publish Date Document Type Title
July, 2023 FDA 483 Hetero Labs Limited - Form 483, 2023-07-21
June, 2016 FDA 483 Pharma-Bio Serv, Inc - Form 483, 2016-07-01
August, 2018 EIR Janssen Ortho LLC - EIR, 2018-08-28
March, 2011 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2011-03-28
August, 2013 FDA 483 Viatris Pharmaceuticals LLC - Form 483, 2013-08-20
March, 2018 FDA 483 Viatris Pharmaceuticals LLC - Form 483, 2018-03-28
March, 2017 FDA 483 Boehringer Ingelheim RCV GmbH & Co KG - Form 483, 2017-03-17
July, 2023 FDA 483 LUPIN LIMITED - Form 483, 2023-07-11
July, 2016 FDA 483 AbbVie Ltd - Form 483, 2016-07-29
June, 2006 FDA 483 Ivax Pharmaceuticals, Inc. - Form 483, 2006-06-02
August, 2010 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2010-08-13
July, 2013 FDA 483 Lilly del Caribe, Inc. - Form 483, 2013-07-23
March, 2023 FDA 483 Janssen Ortho LLC - Form 483, 2023-03-28
August, 2018 FDA 483 Janssen Ortho LLC - Form 483, 2018-08-28
June, 2021 FDA 483 Galephar Pharmaceutical Research Inc - Form 483, 2021-06-09
August, 2018 FDA 483 Response Janssen Ortho LLC - Form 483R, 2018-09-19
June, 2011 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2011-06-15
July, 2019 FDA 483 Zhuhai United Laboratories Co., Ltd. - Form 483, 2019-07-16
January, 2010 FDA 483 McNeil Healthcare LLC. - Form 483, 2010-01-08
July, 2017 FDA 483 Lilly del Caribe, Inc. - Form 483, 2017-07-21
January, 2010 FDA 483 Response McNeil Healthcare LLC. - Form 483R, 2010-02-05

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more